Synthetic CBD-Based Drug Put to Test for Chemotherapy Pain

Synthetic CBD-Based Drug Put to Test for Chemotherapy Pain

Temple University in Philadelphia is collaborating with Neuropathix, a Pennsylvania-based pharmaceutical company, to develop and test a synthetic CBD-based medication for chemotherapy-related pain.

With the synthetic molecule named KLS-13019, this human clinical research, which is still in the pre-launch phase, aims to improve both the absorption capabilities and pain-fighting effectiveness of CBD.

In addition to pain, the researchers focus on a form of nerve dysfunction that frequently occurs in chemotherapy patients and is characterized by uncomfortable tingling sensations that can lead to damage (mainly falls) and early chemotherapy treatment discontinuation.

Temple University researchers demonstrated in April of this year that KLS-13019 might lessen “paclitaxel-induced mechanical sensitivity” in mice (paclitaxel is a chemotherapy treatment), laying the groundwork for the current study.

Another cancer-focused CBD research project has been approved by regulatory authorities, this time by Florida-based biotech developer Enveric Biosciences.

The first phase of a two-part trial assessing the efficacy of a CBD-based medication on glioblastoma, an aggressive form of cancer that affects the brain, was approved by Israel’s Ministry of Health.

The study’s first phase aims to determine the product’s maximal acceptable dose, which is a combination of CBD and the medication temozolomide, after which researchers will add additional medication (clomiphene) to “exclude toxicity.”

The next phase of the trial will examine the effectiveness of the treatment after the maximum safe levels for all three drugs involved have been established.

Cultiva Wellness, a CBD-based mobile app developer, announced that it would add a CBD vending machine to its consumer-focused products. Remote access and touch-free payment processing will be included in the smart vending machine.

The Wellness Pantry is created to complement the functionality of the company’s flagship product, the Cultiva App, which connects CBD customers and brands. It is built with accurate age verification capabilities (through blockchain technology).

Photo by CBD Infos on Unsplash

Leave a Comment

Your email address will not be published. *